Navigation Links
CuraGen Reports First Quarter 2008 Financial Results
Date:4/22/2008

- CR011-vcMMAE in Phase II for melanoma, to begin Phase II for breast

cancer -

- Conference call to be hosted today at 9:00 a.m. EDT -

BRANFORD, Conn., April 22 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) today reported its financial results for the first quarter of 2008. For the quarter ended March 31, 2008, CuraGen reported a net loss of $6.8 million, or $0.12 per share, compared to a net loss of $17.0 million, or $0.31 per share, for the same period in 2007.

During the first quarter, CuraGen incurred costs totaling $1.5 million for milestones related to the advancement of CR011-vcMMAE into Phase II clinical development. Of the decrease in cash and investments of $7.6 million during the first quarter of 2008, $2.6 million was related to non-recurring restructuring payments and payments associated with a previously discontinued program.

As of March 31, 2008, CuraGen had cash, restricted cash and investments of approximately $107.4 million. Following this morning's announced transaction with TopoTarget A/S, CuraGen currently projects a total of approximately $145 million in cash, restricted cash and investments at April 30, 2008.

CuraGen has also revised its 2008 financial guidance. CuraGen anticipates ending 2008 with approximately $135 million of cash and investments compared to previously provided guidance of $90 million. During the second half of 2008, CuraGen anticipates using approximately $6 to $8 million of cash and investments to fund operations.

"During the first quarter we continued to make progress strengthening our balance sheet and working to enhance shareholder value. We believe that our increased cash position and reduced ant
'/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
2. CuraGen Reports Third Quarter 2007 Financial Results
3. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
4. Albemarle Reports Record Quarterly Net Sales and Operating Results
5. Quest Diagnostics Reports Strong Revenue and Earnings Growth in First Quarter 2008
6. Amylin Pharmaceuticals Reports First Quarter Financial Results
7. QMed, Inc. Reports First Quarter Results
8. TeamStaff, Inc. Reports Preliminary Second Quarter 2008 Results
9. Bioniche Reports the Passing of its Board Chair
10. Southwest Bancorp Reports First Quarter 2008 Earnings per Share of $0.36
11. Torchmark Corporation Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... 17, 2013 Daily Gossip Magazine has ... a thorough review of the Tinnitus Miracle treatment ... presents the natural treatment that Coleman suggests ... have tested it. , Based on the information provided ... Tinnitus treatment suggested by Thomas Coleman is different ...
(Date:6/17/2013)... New York, New York (PRWEB) June 17, 2013 ... associated with products manufactured by C.R. Bard, Inc. ... underway in New Jersey’s Atlantic County Superior Court, Bernstein ... a new Consent Order that set forth protocols for ... samples for the litigation’s bellwether cases. Court documents ...
(Date:6/17/2013)... June 17, 2013 The producers of ... new series of reports highlighting how sustainable farming techniques ... growing populations and their demand on food supplies. , ... produced television series airing in markets around the country ... legendary Martin Sheen, who is marking the start of ...
(Date:6/17/2013)... 2013 Ayurveda Chile is the ... or wisdom of life." As a mind-body-spirit medicine, its scope ... of consciousness. Its fundamental philosophy is that disease is the ... In order to re-establish optimal health, one must discover where ... life style which brings us back into perfect harmony and ...
(Date:6/17/2013)... York, NY (PRWEB) June 17, 2013 The ... Yohan Blake to attend the Festival this summer, which will ... 18th through Sunday, August 25th. , Blake professes the ... bananas a day to fuel his world class sprinting ... large volume of fruit is drawing attention. "Yohan Blake believes ...
Breaking Medicine News(10 mins):Health News:Thomas Coleman's Tinnitus Miracle Treatment Review Discloses Alternative Natural Cure 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note New Order in New Jersey C.R. Bard Litigation Concerning Handling of Explants and Tissue Samples 2Health News:Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note New Order in New Jersey C.R. Bard Litigation Concerning Handling of Explants and Tissue Samples 3Health News:Ayurveda Chile Program Offered by Escuela Ayurveda de California in August, 2013 2Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2
... reports the latest research done in Britain claim that ... //cancer successfully after having studied over 2,400 patients. The ... effectiveness of adding the drug epirubicin to regular chemotherapy ... cancer. Both studies reported better results of treatment ...
... government officials continue to extol the virtues of the NHS, ... to protest against the policies of the NHS. // ... and increased staff numbers but NHS staff including doctors, nurses, ... of Westminster to protest aginst disastrous policies. ,Pensioners ...
... that has worked against different strains of Staphylococcus aureus ... promising step towards designing a vaccine which can be used ... study was done by researchers at the University of Chicago ... Infectious Diseases. , Dr. Olaf Schneewind and colleagues at ...
... at the Harvard Medical School and the National Institute on ... found in red wine, and the skin of red ... with calories and may significantly affect the longevity ... journal Nature, explains that a daily intake of ...
... medical consultations and patients are seen tapping the online ... ailments, especially ones they would like to hide in ... scored very high on the search list and back ... of attention.NHS direct, the helpline is known to answer ...
... less inclined to commit suicide as compared to Whites was ... among black Americans. Scientists from the University of Michigan said ... ones own life happens to be the 11th leading cause ... that nearly one in 10 black Americans suffer from suicidal ...
Cached Medicine News:Health News:Wide Differences between NHS staff and ministers 2Health News:Fat or old - Swig red wine to live long says study 2
(Date:6/17/2013)... 2013 Velplex, LLC announced this week that ... that connects buyers and sellers of discount dental ... Why? It,s because the business leaders ... with the dental industry. They have 50 years of ... worked to negotiate some of the best prices in ...
(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24).  The SET (Safety and Efficacy of ...
(Date:6/17/2013)...  Hanger, Inc. (NYSE:  HGR) today announced the signing ... senior secured facilities to an aggregate of up to ... agreement includes a $200 million revolving credit facility and ... agreement was comprised of a $100 million revolving credit ... facility matures on June 17, 2018, and is subject ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... has received U.S. Food and Drug Administration ("FDA") ... for Enoxaparin Sodium Injection in the 100mg/mL and ... equivalent to Sanofi-aventis, LOVENOX®, and is a low ...
... SYDNEY, Sept. 19, 2011 HeartWare International, Inc. (NASDAQ: ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that CEO Doug Godshall is scheduled to present ... Device Day at 1:55 p.m. ET on Thursday, September ...
Cached Medicine Technology:Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 2Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 3HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day 2
... The model 55S Rocking Shaker provides ... and blotted membranes. The very slow ... degree of tilt provide a gentle ... over gels and blotted membranes to ...
Plate Roller...
Conversion Kits For Modular Incubator Chamber...
Multi-Tier Shaker...
Medicine Products: